DK0757994T3 - TCF-mutanter - Google Patents

TCF-mutanter

Info

Publication number
DK0757994T3
DK0757994T3 DK95942271T DK95942271T DK0757994T3 DK 0757994 T3 DK0757994 T3 DK 0757994T3 DK 95942271 T DK95942271 T DK 95942271T DK 95942271 T DK95942271 T DK 95942271T DK 0757994 T3 DK0757994 T3 DK 0757994T3
Authority
DK
Denmark
Prior art keywords
tcf
amino acid
present
activity
acid sequence
Prior art date
Application number
DK95942271T
Other languages
English (en)
Inventor
Kanji Higashio
Masahiko Kinosaki
Kyoji Yamaguchi
Fumie Kobayashi
Masaaki Goto
Akihiko Murakami
Masatsugu Ueda
Yasushi Yamashita
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of DK0757994T3 publication Critical patent/DK0757994T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95942271T 1994-12-27 1995-12-27 TCF-mutanter DK0757994T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33788594 1994-12-27
PCT/JP1995/002708 WO1996020214A1 (fr) 1994-12-27 1995-12-27 Mutant de tcf

Publications (1)

Publication Number Publication Date
DK0757994T3 true DK0757994T3 (da) 2004-01-19

Family

ID=18312917

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95942271T DK0757994T3 (da) 1994-12-27 1995-12-27 TCF-mutanter

Country Status (16)

Country Link
US (2) US6399744B1 (da)
EP (2) EP1275718A3 (da)
JP (1) JP3699482B2 (da)
KR (1) KR100294328B1 (da)
AT (1) ATE248913T1 (da)
AU (1) AU698221B2 (da)
CA (1) CA2183856C (da)
DE (1) DE69531673T2 (da)
DK (1) DK0757994T3 (da)
ES (1) ES2206523T3 (da)
FI (1) FI116223B (da)
HU (1) HU220167B (da)
NO (1) NO319022B1 (da)
NZ (1) NZ298142A (da)
WO (1) WO1996020214A1 (da)
ZA (1) ZA9510982B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1275718A3 (en) * 1994-12-27 2003-03-19 Daiichi Pharmaceutical Co., Ltd. TCF mutant
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
ATE344050T1 (de) 1997-03-14 2006-11-15 Daiichi Seiyaku Co Verwendung von tcf-ii zur behandlung von durch krebs verursachtem gewichtsverlust, anaemie und tnf-erhöhung
JP3961064B2 (ja) * 1997-03-28 2007-08-15 第一製薬株式会社 腎疾患予防及び／又は治療剤
KR100552434B1 (ko) * 1997-03-28 2006-05-16 다이이치세이야꾸 가부시끼가이샤 신질환 예방 및/또는 치료제_
GB9709453D0 (en) * 1997-05-10 1997-07-02 Imp Cancer Res Tech Polypedtides and their use in therapy
EP1054899A2 (de) * 1998-02-21 2000-11-29 Max-Delbrück-Centrum Für Molekulare Medizin Mittel zur therapie von menschlichen erkrankungen, ausgehend von beta-catenin, seine herstellung und seine verwendung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
ES2132087T3 (es) * 1990-07-13 1999-08-16 Snow Brand Milk Products Co Ltd Plasmidios que contienen adn que codifica la secuencia de aminoacidos de tcf-ii, celulas transformadas y produccion de la sustancia fisiologicamente activa usando las mismas.
WO1993023541A1 (en) * 1992-05-18 1993-11-25 Genentech, Inc. Hepatocyte growth factor variants
KR100260964B1 (ko) * 1992-07-16 2000-07-01 쇼노 카츄야 Tcf-ii를 유효성분으로 하는 혈액응고 정상화제
WO1994014845A1 (en) * 1992-12-28 1994-07-07 Snow Brand Milk Products Co., Ltd. Modified tcf
EP1275718A3 (en) * 1994-12-27 2003-03-19 Daiichi Pharmaceutical Co., Ltd. TCF mutant
JP3961064B2 (ja) * 1997-03-28 2007-08-15 第一製薬株式会社 腎疾患予防及び／又は治療剤
JPH1129493A (ja) * 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び／又は治療剤

Also Published As

Publication number Publication date
EP0757994A4 (en) 1998-10-21
KR970701206A (ko) 1997-03-17
AU4355196A (en) 1996-07-19
JP3699482B2 (ja) 2005-09-28
EP0757994B1 (en) 2003-09-03
ZA9510982B (en) 1996-08-22
HU9602174D0 (en) 1996-10-28
DE69531673T2 (de) 2004-07-08
ATE248913T1 (de) 2003-09-15
NO319022B1 (no) 2005-06-06
NO963552L (no) 1996-10-28
HUT75236A (en) 1997-04-28
US6399744B1 (en) 2002-06-04
DE69531673D1 (de) 2003-10-09
NZ298142A (en) 1997-08-22
KR100294328B1 (ko) 2001-09-17
ES2206523T3 (es) 2004-05-16
NO963552D0 (no) 1996-08-26
EP1275718A2 (en) 2003-01-15
HU220167B (hu) 2001-11-28
AU698221B2 (en) 1998-10-29
FI963313A0 (fi) 1996-08-26
CA2183856A1 (en) 1996-06-28
EP0757994A1 (en) 1997-02-12
EP1275718A3 (en) 2003-03-19
FI963313A (fi) 1996-08-26
CA2183856C (en) 2006-11-07
WO1996020214A1 (fr) 1996-07-04
US20020165358A1 (en) 2002-11-07
FI116223B (fi) 2005-10-14

Similar Documents

Publication Publication Date Title
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
PH22461A (en) Preparation of functional human urokinase protein
AU8502198A (en) Method for treating vascular proliferative diseases with p27 and fusions thereof
DE69531673D1 (de) Tcf mutante
CA2509508A1 (en) Tcf mutant
DK0667872T3 (da) Mutantinterleukin 6 med forbedret biologisk aktivitet i forhold til vildtype-interleukin 6
ES2120958T3 (es) Nuevas proteinas con actividad de oncostatina m y procedimiento para su preparacion.